CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study

Food and Chemical Toxicology

Volumn 42, Issue 6, 2004, Pages 869-878

  Moonen, Harald J J ^a   Moonen, Edwin J C ^a   Maas, Lou ^a   Dallinga, Jan W ^a   Kleinjans, Jos C S ^a   De Kok, Theo M C M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

1F polymorphism; 2 amino 1 methyl 6 phenylimidazo 4,5 b pyridine; CYP1A2; Cytochrome P450 1A2; Cytochrome P4501A2; Genotype; HCA; Heterocyclic aromatic amines; N acetyltransferase; N acetyltransferase 2; NAT2; Phenotype; PhIP; Urinary PhIP excretion

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ACYLTRANSFERASE; CAFFEINE; CYTOCHROME P450 1A2;

ADOLESCENT; ADULT; ARTICLE; CALORIC INTAKE; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; INTERMETHOD COMPARISON; NORMAL HUMAN; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; COOKERY; CYTOCHROME P-450 CYP1A2; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMIDAZOLES; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 1942534114     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2004.01.010     Document Type: Article

References (55)

1. Alexander J., Reistad R., Hegstad S., Frandsen H., Ingebrigtsen K., Paulsen J.E., Becher G. Biomarkers of exposure to heterocyclic amines. approaches to improve the exposure assessment Food and Chemical Toxicology. 40:2002;1131-1137.
2. Bell D.A., Taylor J.A., Butler M.A., Stephens E.A., Wiest J., Brubaker L.H., Kadlubar F.F., Lucier G.W. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis. 14:1993;1689-1692.
3. Blum M., Demierre A., Grant D.M., Heim M., Meyer U.A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proceedings of the National Academy of Sciences of the U.S.A. 88:1991;5237-5241.
4. Boobis A.R., Lynch A.M., Murray S., de la Torre R., Solans A., Farré M., Segura J., Gooderham N.J., Davies D.S. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Research. 54:1994;89-94.
5. Butler M.A., Lang N.P., Young J.F., Caporaso N.E., Vineis P., Hayes R.B., Teitel C.H., Massengill J.P., Lawsen M.F., Kadlubar F.F. Determination of CYP1A2 and acetylator phenotypes in several human populations by analysis of caffeine urinary metabolites. Pharmacogenetics. 2:1992;116-127.
6. Campbell M.E., Spielberg S.P., Kalow W. A urinary metabolite ratio that reflects systemic caffeine clearance. Clinical Pharmacology and Therapeutics. 42:1987;157-165.
7. Chevalier D., Cauffiez C., Allorge D., Lo-Guidice J.M., Lhermitte M., Lafitte J.J., Broly F. Five novel natural allelic variants - 951A>C, 1042G>A (D348N), 1156A>T (I386F), 1216G>A (C406Y) and 1291C>T (C431Y) - of the human CYP1A2 gene in a French Caucasian population. Human Mutagenesis. 17:2001;355-356.
8. Christiansen L., Bygum A., Jensen A., Thomsen K., Brandrup F., Hørder M., Petersen N.E. Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Human Genetics. 107:2000;612-614.
9. Crofts F.G., Sutter T.R., Strickland P.T. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis. 19:1998;1969-1973.
10. Doll M.A., Fretland A.J., Deitz A.C., Hein D.W. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification. Analytical Biochemistry. 231:1995;413-420.
11. Eisenbrand G., Tang W. Food-borne heterocyclic amines. Chemistry, formation, occurrence and biological activities. A literature review. Toxicology. 84:1993;1-82.
12. Felton J.S., Knize M.G., Shen N.H., Lewis P.R., Andresen B.D., Happa J., Hatch F.T. The isolation and identification of a new mutagen from fried ground beef. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Carcinogenesis. 7:1986;1081-1086.
13. Friesen M.D., Rothman N., Strickland T. Concentration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in urine and alkali-hydrolyzed urine after consumption of charbroiled beef. Cancer Letters. 173:2001;43-51.
14. Fuhr U., Rost K.L., Engelhardt R., Sachs M., Liermann D., Belloc C., Beaune P., Janezic S., Grant D., Meyer U.A., Staib A.H. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. Pharmacogenetics. 6:1996;159-176.
15. Giovannucci E., Willett W. Dietary factors and risk of colon cancer. Annals of Medicine. 26:1994;443-452.
16. Grant D.M., Tang B.K., Kalow W. A simple test for acetylator phenotype using caffeine. British Journal of Clinical Pharmacology. 17:1984;459-464.
17. Gross G.A., Gruter A. Quantitation of mutagenic/carcinogenic heterocyclic amines in food products. Journal of Chromatography. 592:1992;271-278.
18. Gross M., Kruisselbrink T., Anderson K., Lang N., McGovern P., Delongchamp R., Kadlubar F. Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiology, Biomarkers and Prevention. 8:1999;683-692.
19. Huang J.D., Guo W.C., Lai M.D., Guo Y.L., Lambert G.H. Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. Drug Metabolism and Disposition. 27:1999;98-101.
20. Kadlubar F.F., Butler M.A., Kaderlik K.R., Chou H.-C., Lang N.P. Polymorphisms for aromatic amine metabolism in humans. relevance for human carcinogenesis Environmental Health Perspectives. 98:1992;69-74.
21. Kadlubar, F.F., Kaderlik, K.R., Mulder, G.J., Lin, D., Butler, M.A., Teitel, C.E., Minchin, R.F., Ilett, K.F., Friesen, M.D., Bartsch, H., Nagao, M., Esumi, H., Sugimura, T., Lang, N.P., 1995. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis. In: Adamson, R.H., Gustafsson, J., Å., Landi, M.T., Sinha, R., Lang, N.P., Kadlubar, F. F., 1999. Human cytochrome P4501A2. In: Vineis, P., Malats, N., Lang, M., d'Errico, A., Caporaso, N., Cuzik, J., Boffetta, P. (Eds.), Metabolic Polymorphisms and Susceptibility to Cancer. IARC Scientific Publications No. 148, IARC, Lyon, pp. 173-195.
22. Knize M.G., Dolbeare F.A., Carroll K.L., Moore D.H. II, Felton J.S. Effect of cooking time and temperature on the heterocyclic amine content of fried beef patties. Food and Chemical Toxicology. 32:1994;595-603.
23. Knize M.G., Sinha R., Rothman N., Brown E.D., Salmon C.P., Levander O.A., Cunningham P.L., Felton J.S. Heterocylic amine content in fast-food meat products. Food and Chemical Toxicology. 33:1995;545-551.
24. Knize M.G., Kulp K.S., Salmon C.P., Keating G.A., Felton J.S. Factors affecting human heterocyclic amine intake and the metabolism of PhIP. Mutation Research. 506-507:2002;153-162.
25. Krul C., Hageman G. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reverse-phase high-performance liquid chromatography. Journal of Chromatography B. 709:1998;27-34.
26. Kulp K.S., Knize M.G., Malfatti M.A., Salmon C.P., Felton J.S. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine following consumption of a single cooked chicken meal in humans. Carcinogenesis. 21:2000;2065-2072.
27. Landi M.T., Sinha R., Lang N.P., Kadlubar F.F. Human cytochrome P4501A2. Vineis P., Malats N., Lang M.et al. Metabolic Polymorphism and Susceptibility to Cancer. 1999;173-195 IARC Scientific Publications 148, Lyon, France.
28. Lang N.P., Butler M.A., Massengill J.P., Lawson M., Stotts R.C., Hauer-Jensen M., Kadlubar F.F. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiology, Biomarkers and Prevention. 3:1994;675-682.
29. Le Marchand L., Hankin J.H., Wilkens L.R., Pierce L.M., Franke A., Kolonel L.N., Seifried A., Custer L.J., Chang W., Lum-Jones A., Donlon T. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiology, Biomarkers and Prevention. 10:2001;1259-1266.
30. Le Marchand L., Hankin J.H., Pierce L.M., Sinha R., Nerurkar P.V., Franke A.A., Wilkens L.R., Kolonel L.N., Donlon T., Seifried A., Custer L.J., Lum-Jones A., Chang W. Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutation Research. 506-507:2002;205-214.
31. Lynch A.M., Knize M.G., Boobis A.R., Gooderham N.J., Davies D.S., Murray S. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef. Cancer Research. 52:1992;6216-6223.
32. MacLeod S., Sinha R., Kadlubar F.F., Lang N.P. Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2. Mutation Research. 376:1997;135-142.
33. MacLeod S.L., Tang Y.-M., Yokoi T., Kamataki T., Doublin S., Lawson B., Massengill J., Kadlubar F.F., Lang N.P. The role of a recently discovered genetic polymorphism in the regulation of the human CYP1A2 gene. Proceedings of the American Association for Cancer Research. 39:1998;396.
34. 14C]2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine metabolites in humans. Carcinogenesis. 20:1999;705-713.
35. Moonen H.J.J., Briedé J.J., van Maanen J.M.S., Kleinjans J.C.S., de Kok T.M.C.M. Generation of free radicals and induction of DNA adducts by activation of heterocyclic aromatic amines via different metabolic pathways in vitro. Molecular Carcinogenesis. 35:2002;196-203.
36. Nakajima M., Yokoi T., Mizutani M., Kinoshita M., Funayama M., Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene. effect on the CYP1A2 inducibility in humans Journal of Biochemistry. 125:1999;803-808.
37. Potter J.D. Colorectal cancer. molecules and populations Journal of the National Cancer Institute. 91:1999;916-932.
38. Reistad R., Rossland O.J., Latva-Kala K.J., Rasmussen T., Vikse R., Becher G., Alexander J. Heterocyclic aromatic amines in human urine following a fried meat meal. Food and Chemical Toxicology. 35:1997;945-955.
39. Sachse C., Brockmöller J., Bauer S., Roots I. Functional significance of a C→ A polymorphism in intron I of the cytochrome P450 CYP1a2 gene tested with caffeine. British Journal of Clinical Pharmacology. 47:1999;445-449.
40. Sachse C., Smith G., Wilkie M.J.V., Barrett J.H., Waxman R., Sullivan F., Forman D., Bishop D.T., Wolf C.R. the Colorectal Cancer Study Group A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis. 23:2002;1839-1849.
41. Sachse C., Bhambra U., Smith G., Lightfoot T.J., Barrett J.H., Scollay J., Garner R.C., Boobis A.R., Wolf C.R., Gooderham N.J. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls. allele frequencies, linkage disequilibrium and influence on caffeine metabolism British Journal of Clinical Pharmacology. 55:2003;68-76.
42. Salmon C.P., Knize M.G., Felton J.S. Effects of marinating on heterocyclic amine carcinogen formation in grilled chicken. Food and Chemical Toxicology. 35:1997;433-441.
43. Sinha R., Rothman N., Brown E., Mark S., Hoover R., Caporaso N., Levander O., Knize M., Lang N., Kadlubar F. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans. Cancer Research. 54:1994;6154-6159.
44. Sinha R., Caporaso N. Heterocyclic amines, cytochome P4501A2, and N-acetyltransferase. issues involved in incorporating putative genetic susceptibility markers into epidemiological studies Annals of Epidemiology. 7:1997;350-356.
45. Skog K., Steineck G., Augustsson K., Jägerstad M. Effects of cooking temperature on the formation of heterocyclic amines in fried meat products and pan residues. Carcinogenesis. 16:1995;861-867.
46. Skog K.I., Johansson M.A., Jagerstad M.I. Carcinogenic heterocyclic aromatic amines in model systems and cooked foods. a review on formation, occurrence and intake Food and Chemical Toxicology. 36:1998;879-896.
47. Skog K. Problems associated with the determination of heterocyclic amines in cooked foods and human exposure. Food and Chemical Toxicology. 40:2002;1197-1203.
48. Smith C.A., Wadelius M., Gough A.C., Harrison D.J., Wolf C.R., Rane A. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. Journal of Medical Genetics. 34:1997;758-760.
49. Solyakov A., Skog K. Screening for heterocyclic aromatic amines in chicken cooked in various ways. Food and Chemical Toxicology. 40:2002;1205-1211.
50. 2-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans. Carcinogenesis. 23:2002;831-838.
51. Sugimura T., Nagao M., Kawachi T., Honda M., Yahagi T., Seino Y., Sato S., Matsukura N., Matsushima T., Shirai A., Sawamura M., Matsumoto H. Mutagen-carcinogens in food, with special reference to highly mutagenic pyrolytic products in broiled foods. Hiatt H.H., Watson J.D., Winsten J.A. Origins of Human Cancer, Book C. 1977;1561-1567 Cold Spring Harbor Laboratory Press, New York, NY.
52. Tang B.K., Zhou Y., Kadar D., Kalow W. Caffeine as a probe for CYP1A2 activity. potential influence of renal factors on urinary phenotypic trait measurements Pharmacogenetics. 4:1994;117-124.
53. Turesky R.J., Lang N.P., Butler M.A., Teitel C.H., Kadlubar F.F. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis. 12:1999;1839-1845.
54. Vatsis K.P., Weber W.W., Bell D.A., Dupret J., Price Evans D.A., Grant D.M., Hein D.W., Lin H.J., Meyer U.A., Relling M.V., Sim E., Suzuki T., Yamazoe Y. Nomenclature for N-acetyltransferases. Pharmacogenetics. 5:1995;1-17.
55. Vistisen K., Loft S., Poulsen H.E. Cytochrome P450 1A2 activity in man measured by caffeine metabolism. effect of smoking, broccoli and exercise Advances in Experimental Medicine and Biology. 283:1991;407-411.